DAVID FALDMO: Open Payments
NPI 1699769794 · SOUTH SIOUX CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 23 payments from 8 companies in 2025. Trend: 2023 $332 · 2024 $343 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $209 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| ViiV Healthcare Company | 1 | $40 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: Ozempic, Wegovy, DOVATO, FANAPT, VAXELIS, VAXNEUVANCE, Rybelsus, GVOKE HYPOPEN.
Industry payments across NE — which companies pay providers there.
